Aetion solutions enable manufacturers to scale their real-world evidence (RWE) capabilities and engage with payers.
Life science companies can now confidently scale their internal real-world evidence capabilities using proprietary or licensed data assets. With bottlenecks on medically trained data scientists and application run time eliminated, Aetion clients experience 10x productivity improvements, while maintaining the highest levels of scientific quality and transparency.
Aetion provides life science companies a complete solution for collaborative analytics and payer engagement. Building upon the essential evidence generated with the Aetion Evidence Platform, Aetion customers work with payers in a transparent, data-driven environment to enable value-based dialog and contracting.
The Aetion Evidence Platform enables manufacturers to support 1:1 or multi-party interactions with regulators in the US, Europe and other regions, including rapid regulatory response and single- and multi-database PASS studies.